Evidence map›Paper›PMID 41997931›Full record

ArticleCell death & disease2026

Correction: Chloroquine overcomes chemotherapy resistance and suppresses cancer metastasis by eradicating dormant cancer cells.

Marina A Mikeladze, Liubov S Kuznetcova, Elena Y Komarova, Margarita A Galcheva, Vladimir F Lazarev, Lev A Khamaev, Maria A Konanova, Yana A Gladova, Anna B Danilova, Boris A Margulis and 2 more

Abstract readPublished Erratum
In one paragraph

Article in Cell death & disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Marina A Mikeladze *Institute of Cytology of Russian Academy of Sciences, Tikhoretsky prospect, 4, S.Petersburg, Russia.
Liubov S Kuznetcova *Institute of Cytology of Russian Academy of Sciences, Tikhoretsky prospect, 4, S.Petersburg, Russia.
Elena Y KomarovaInstitute of Cytology of Russian Academy of Sciences, Tikhoretsky prospect, 4, S.Petersburg, Russia.
Margarita A GalchevaInstitute of Cytology of Russian Academy of Sciences, Tikhoretsky prospect, 4, S.Petersburg, Russia.ORCID http://orcid.org/0009-0002-3176-281X
Vladimir F LazarevInstitute of Cytology of Russian Academy of Sciences, Tikhoretsky prospect, 4, S.Petersburg, Russia.ORCID http://orcid.org/0000-0002-7117-6789
Lev A KhamaevInstitute of Cytology of Russian Academy of Sciences, Tikhoretsky prospect, 4, S.Petersburg, Russia.ORCID http://orcid.org/0009-0008-9673-8494
Maria A KonanovaInstitute of Cytology of Russian Academy of Sciences, Tikhoretsky prospect, 4, S.Petersburg, Russia.
Yana A GladovaInstitute of Cytology of Russian Academy of Sciences, Tikhoretsky prospect, 4, S.Petersburg, Russia.
Anna B DanilovaN.N.Petrov Scientific Medical Research Center of Oncology, Leningradskaya str, 68, Pesochny, S.Petersburg, Russia.ORCID http://orcid.org/0000-0003-4796-0386
Boris A MargulisInstitute of Cytology of Russian Academy of Sciences, Tikhoretsky prospect, 4, S.Petersburg, Russia.ORCID http://orcid.org/0000-0002-2608-0147
Bashar A AlhasanInstitute of Cytology of Russian Academy of Sciences, Tikhoretsky prospect, 4, S.Petersburg, Russia.ORCID http://orcid.org/0000-0002-2239-2872
Irina V GuzhovaInstitute of Cytology of Russian Academy of Sciences, Tikhoretsky prospect, 4, S.Petersburg, Russia. irina.guzhova@incras.ru.ORCID http://orcid.org/0000-0002-8775-7713

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41997931
PMCPMC13090342

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.